Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Antidepressant Response to Ketamine and Impact on Healthcare Utilization After Administration in the Emergency Department

NCT04266288 is registered in ClinicalTrials.gov with MercyOne Des Moines Medical Center as lead sponsor.

NCT NCT04266288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04266288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Antidepressant Response to Ketamine and Impact on Healthcare Utilization After Administration in the Emergency Department
Lead sponsor
MercyOne Des Moines Medical Center
Phase
Phase 4
Overall status
Completed
Start date
October 18, 2019
Completion date
May 31, 2020
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depression acute, depression and suicide, depression severe, suicidal ideation